2014 Summit Plenary - PREPPING FOR PREP: BRINGING PREP TO SCALE FOR HIV PREVENTION
In July 2012 the FDA approved daily Truvada as the first drug to be used to prevent HIV infection. Known as Pre-exposure prophylaxis (PrEP), this new HIV prevention approach where HIV-negative individuals use anti-HIV medications to reduce their risk of becoming infected has been known to reduce transmission by more than 92% when taken on a daily basis.
But will it work in the real world? With the rollout of PrEP at different stages across the country and globe, what do we know for sure about this new approach? Is it safe? What are the barriers to access and adherence? What does it mean for gay/bi men and for women? How is it changing the conversation about sexual health? Can we afford to sustainably implement PrEP?
In this moderated plenary session, organized by the San Francisco AIDS Foundation, a doctor, an activist, a PrEP user, and a popular blogger on the topic will explore the controversial community debate taking place around the use of PrEP, and will share feedback and data from the start-up of a new PrEP clinic operating within San Francisco AIDS Foundation's sexual health services clinic. Significant time will be also given to discussing how those in attendance might make a difference in their local fight to end HIV transmission.
Moderator: Dr. Robert Grant, San Francisco AIDS Foundation Speakers: Nadji Dawkins, CRUSH (Connecting Resources for Urban Sexual Health); Damon Jacobs, PrEP Educator/Blogger; Dazon Dixon Diallo, SisterLove, Inc.